AU6368500A - Materials and processes for controlled release of thioamide moiety-containing therapeutic agents by linking to thiol-containing polymers - Google Patents
Materials and processes for controlled release of thioamide moiety-containing therapeutic agents by linking to thiol-containing polymersInfo
- Publication number
- AU6368500A AU6368500A AU63685/00A AU6368500A AU6368500A AU 6368500 A AU6368500 A AU 6368500A AU 63685/00 A AU63685/00 A AU 63685/00A AU 6368500 A AU6368500 A AU 6368500A AU 6368500 A AU6368500 A AU 6368500A
- Authority
- AU
- Australia
- Prior art keywords
- thiol
- linking
- processes
- materials
- therapeutic agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35851599A | 1999-07-22 | 1999-07-22 | |
US09358515 | 1999-07-22 | ||
US09/621,109 US6468522B1 (en) | 1999-07-22 | 2000-07-21 | Controlled release of thioamide moiety-containing therapeutic agents |
US09621109 | 2000-07-21 | ||
PCT/US2000/020090 WO2001007013A2 (en) | 1999-07-22 | 2000-07-24 | Thioamide moiety-containing polymer drug conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6368500A true AU6368500A (en) | 2001-02-13 |
Family
ID=27000094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU63685/00A Abandoned AU6368500A (en) | 1999-07-22 | 2000-07-24 | Materials and processes for controlled release of thioamide moiety-containing therapeutic agents by linking to thiol-containing polymers |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6368500A (en) |
CA (1) | CA2380050A1 (en) |
WO (1) | WO2001007013A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1581582B2 (en) | 2003-01-06 | 2017-06-07 | Nektar Therapeutics | Thiol-selective water-soluble polmer derivatives |
EP1864682A1 (en) * | 2006-06-09 | 2007-12-12 | Sanofi-Aventis | Leptomycin derivatives |
-
2000
- 2000-07-24 CA CA002380050A patent/CA2380050A1/en not_active Abandoned
- 2000-07-24 WO PCT/US2000/020090 patent/WO2001007013A2/en active Application Filing
- 2000-07-24 AU AU63685/00A patent/AU6368500A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001007013A9 (en) | 2002-11-14 |
CA2380050A1 (en) | 2001-02-01 |
WO2001007013A3 (en) | 2001-10-25 |
WO2001007013A2 (en) | 2001-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
AU4300701A (en) | Methods and compositions for administration of therapeutic reagents | |
PL337867A1 (en) | Oral preparation of controllable opioidic analgesic agent release | |
AU2001286677A1 (en) | Controlled release of substances | |
AR027907A1 (en) | COMPOSITION OF CONTROLLED RELEASE | |
AU2002252227A1 (en) | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | |
EP1189597A4 (en) | Oil-core compositions for the sustained release of hydrophobic drugs | |
AU782631C (en) | Novel heterocyclic compounds and salts thereof and medicinal use of the same | |
AU2003243561A1 (en) | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
AU8038998A (en) | Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters | |
AU7731700A (en) | Low dose ifn-gamma for treatment of disease | |
HUP0201038A2 (en) | Preparations for the application of anti-inflammatory agents | |
AU2001232948A1 (en) | Controlled release of drugs | |
AU5820900A (en) | Capsule for the controlled release of active substances | |
NO20014049L (en) | Controlled release formulation for treatment of COPD | |
HUP0201405A3 (en) | Pharmaceutical composition for therapeutic use of melatonin | |
AU4628800A (en) | Procedure and device for the moulding of composite materials | |
AU2002351388A1 (en) | Methods and compositions for controlled release of drugs | |
IL152224A0 (en) | Stable crystals of thiazolidinedione derivative and process for the preparation thereof | |
AU3699000A (en) | Use of protein conformation for the protection and release of chemical compounds | |
AU2670600A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence | |
AU2001221695A1 (en) | Solid pharmaceutical compositions for controlled release of active substances | |
AU6368500A (en) | Materials and processes for controlled release of thioamide moiety-containing therapeutic agents by linking to thiol-containing polymers | |
HUP0202741A3 (en) | Pharmaceutical composition available for the therapeutic management of endometriosis and fallopian tube obstruction and process for its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |